These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24857257)

  • 1. [Malignant insulinoma: recommendations for workup and treatment].
    Baudin E; Caron P; Lombard-Bohas C; Tabarin A; Mitry E; Reznick Y; Taieb D; Pattou F; Goudet P; Vezzosi D; Scoazec JY; Cadiot G; Borson-Chazot F; Do Cao C;
    Presse Med; 2014 Jun; 43(6 Pt 1):645-59. PubMed ID: 24857257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of malignant insulinoma responsive to somatostatin analogs treatment.
    Caliri M; Verdiani V; Mannucci E; Briganti V; Landoni L; Esposito A; Burato G; Rotella CM; Mannelli M; Peri A
    BMC Endocr Disord; 2018 Dec; 18(1):98. PubMed ID: 30591061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: case report and review of the literature.
    Scharf M; Mueller D; Koenig U; Pfestroff A; Nimphius W; Figiel J; Rinke A; Koenig A; Gress T
    Pancreatology; 2014; 14(6):542-5. PubMed ID: 25459566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of malignant pancreatic endocrine tumour.
    Wang L; Zhao YP; Lee CI; Liao Q
    Chin Med Sci J; 2004 Jun; 19(2):130-3. PubMed ID: 15250251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant insulinoma].
    Tóth M; Szücs N; Jakab Z; Doros A; Nemes Z; Rácz K
    Orv Hetil; 2011 Mar; 152(10):398-402. PubMed ID: 21354956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant insulinoma misdiagnosed and treated as epilepsy.
    Louda F; Chadli A; Elaziz S; Elghomari H; Farouqi A
    Ann Endocrinol (Paris); 2013 Feb; 74(1):53-5. PubMed ID: 23351560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of insulin-secreting pancreatic islet cell tumors in ferrets: 57 cases (1986-1994).
    Caplan ER; Peterson ME; Mullen HS; Quesenberry KE; Rosenthal KL; Hoefer HL; Moroff SD
    J Am Vet Med Assoc; 1996 Nov; 209(10):1741-5. PubMed ID: 8921033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinoma: a review of current management.
    Bliss RD; Carter PB; Lennard TW
    Surg Oncol; 1997; 6(1):49-59. PubMed ID: 9364660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant insulinoma: Report of 6 patients and literature review.
    Shao Y; Qu YQ; Wang XL; Song ZG; Guo QH; Dou JT; Ba JM; Lü ZH; Mu YM
    Neuro Endocrinol Lett; 2016 Jul; 37(3):189-192. PubMed ID: 27618603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulinoma: what symptomatology?].
    Uebersax R; Cananau S; Beuret P; Zahnd G
    Rev Med Suisse Romande; 1984 Sep; 104(9):733-8. PubMed ID: 6095399
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of insuloma patients with refractory hypoglycemia.
    Meleo K
    Probl Vet Med; 1990 Dec; 2(4):602-9. PubMed ID: 1983699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant insulinoma: recommendations for characterisation and treatment.
    Baudin E; Caron P; Lombard-Bohas C; Tabarin A; Mitry E; Reznick Y; Taieb D; Pattou F; Goudet P; Vezzosi D; Scoazec JY; Cadiot G; Borson-Chazot F; Do Cao C; ;
    Ann Endocrinol (Paris); 2013 Dec; 74(5-6):523-33. PubMed ID: 23993836
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of malignant insulinoma.
    Ferrer-García JC; Iranzo González-Cruz V; Navas-DeSolís S; Civera-Andrés M; Morillas-Ariño C; Merchante-Alfaro A; Caballero-Díaz C; Sánchez-Juan C; Camps Herrero C
    Clin Transl Oncol; 2013 Sep; 15(9):725-31. PubMed ID: 23460559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolization of an insulinoma of the pancreas with trisacryl gelatin microspheres as definitive treatment.
    Rott G; Biggemann M; Pfohl M
    Cardiovasc Intervent Radiol; 2008; 31(3):659-62. PubMed ID: 17922161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the Patient: Insulinoma.
    Hofland J; Refardt JC; Feelders RA; Christ E; de Herder WW
    J Clin Endocrinol Metab; 2024 Mar; 109(4):1109-1118. PubMed ID: 37925662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinoma of genetic aetiology.
    Borson-Chazot F; Cardot-Bauters C; Mirallie É; Pattou F;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):200-2. PubMed ID: 23769271
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades.
    Yu J; Ping F; Zhang H; Li W; Yuan T; Fu Y; Feng K; Xia W; Xu L; Li Y
    BMC Endocr Disord; 2018 Dec; 18(1):92. PubMed ID: 30522468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumors of the pancreas.
    Miglani A; Kar P
    Trop Gastroenterol; 2006; 27(1):4-10. PubMed ID: 16910053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective therapeutic embolization in malignant insulinoma].
    Civera Andrés M; Real Collado JT; Martínez Usó I; Ampudia Blasco FJ; Carmena Rodríguez R
    Rev Clin Esp; 2000 Oct; 200(10):548-50. PubMed ID: 11153238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Insulinoma Is Largely Derived From Nonfunctioning Pancreatic Neuroendocrine Tumors: A Contemporary View.
    Yu R
    Pancreas; 2020 Jul; 49(6):733-736. PubMed ID: 32590616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.